GRIFOLS | GRF - Des Atouts





Des Atouts Changement Date
Alcon AG USD 31.1B 521M 2026-06
Almirall EUR 2.37B 29.97M 2026-06
Amadeus IT EUR 11.76B 332.2M 2026-06
Amarin USD 624.36M 21.4M 2026-06
argenx SE USD 10.03B 1.35B 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
Bayer EUR 107.29B 659M 2026-06
Cie Automotive EUR 5.68B 97.53M 2025-12
Demant DKK 40.03B 951M 2026-06
Ence Energia y Celulosa EUR 1.65B 9.23M 2026-03
Essilor EUR 65.06B 1.16B 2026-06
Ferrovial EUR 27.22B 201M 2026-06
Fresenius EUR 41.84B 526M 2026-06
Fresenius Medical Care EUR 31.29B 174.35M 2026-06
Genmab DKK 12.52B 139M 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
GRIFOLS EUR 20.09B 12M 2026-06
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Inditex EUR 36.61B 125M 2026-06
Lakefront Biotherapeutics EUR 3.35B 21.24M 2026-06
Merck EUR 52.69B 383M 2026-06
Novartis USD 122.03B 3.5B 2026-06
Philips EUR 26.7B 565M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Smith & Nephew USD 11.01B 321M 2026-06
UCB EUR 18.16B 971M 2025-12
Viscofan EUR 1.53B 12.29M 2026-06